Puma Biotechnology, Inc.
PBYI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401667
In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Puma Biotechnology, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 157 | 3 | 160 | +6 |
| Shares | 37.9M | 25.7K | 38.7M | +835.0K (+2.2%) |
| Value | $241.8M | $164.3K | $313.6M | +$71.9M (+29.8%) |
3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Puma Biotechnology, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wellington Management Group LLP | 126,091 | $1.02M | 0.00% |
| Trexquant Investment LP | 72,223 | $585.7K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 26,222 | $212.7K | 0.00% |
| Martingale Asset Management L P | 25,364 | $205.7K | 0.00% |
| Spark Investment Management LLC | 17,000 | $137.9K | 0.27% |
| Lido Advisors, LLC | 15,045 | $122.0K | 0.00% |
| R Squared Ltd | 11,991 | $97.2K | 0.05% |
| JustInvest LLC | 10,408 | $84.4K | 0.00% |
| Intech Investment Management LLC | 10,210 | $82.8K | 0.00% |
| Kemnay Advisory Services Inc. | 3,370 | $27.3K | 0.00% |
| Global Retirement Partners, LLC | 1,492 | $12.1K | 0.00% |
| Simplex Trading, LLC | 1,041 | $8.44K | 0.00% |
| Signaturefd, LLC | 367 | $2.98K | 0.00% |
| Ameritas Advisory Services, LLC | 312 | $2.53K | 0.00% |
| Steward Partners Investment Advisory, LLC | 250 | $2.03K | 0.00% |
| Wall Street Access Asset Management, LLC | 180 | $1.46K | 0.00% |
| Quarry LP | 75 | $608 | 0.00% |
| Parallel Advisors, LLC | 49 | $397 | 0.00% |
| National Bank of Canada | 19 | $154 | 0.00% |
| Caitong International Asset Management Co., Ltd | 5 | $41 | 0.00% |
| Clearstead Advisors, LLC | 2 | $17 | 0.00% |
Sold out (15)
Institutions that held Puma Biotechnology, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Citadel Advisors LLC | 29,959 | $191.4K |
| Virtus ETF Advisers LLC | 29,347 | $187.5K |
| Engineers Gate Manager LP | 28,600 | $182.8K |
| Lazard Asset Management LLC | 17,970 | $114.8K |
| Quadrature Capital Ltd | 16,745 | $107.0K |
| Ashton Thomas Private Wealth, LLC | 13,500 | $86.3K |
| HRT Financial LP | 13,073 | $83.0K |
| Cambridge Investment Research Advisors, Inc. | 12,563 | $80.0K |
| Abacus Wealth Partners, LLC | 11,199 | $71.6K |
| Stokes Family Office, LLC | 10,092 | $64.5K |
| MAI Capital Management | 7,558 | $48.3K |
| Intentional Wealth Strategies, LLC | 1,128 | $7.21K |
| Root Financial Partners, LLC | 269 | $1.72K |
| Frazier Financial Advisors, LLC | 183 | $1.17K |
| Wealth Preservation Advisors, LLC | 1 | $6 |
Not filed for Q2 2026 yet (3)
Institutions that held Puma Biotechnology, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| CWM, LLC | 15,263 | $97.5K |
| DGS Capital Management, LLC | 10,418 | $66.6K |
| Sunbelt Securities, Inc. | 30 | $192 |